Gain Therapeutics Q1 2022 Earnings Review
Tuesday, 26 March 2024, 19:26
Gain Therapeutics Q1 2022 Earnings Review
Gain Therapeutics released its financial report for the first quarter of 2022, revealing a GAAP EPS of -$1.71, missing expectations by $0.14. The company's revenue of $0.05M was also below projections, with a shortfall of $0.25M.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.